96 related articles for article (PubMed ID: 10380016)
1. Monoclonal antibodies directed against AFAP-110 recognize species-specific and conserved epitopes.
Qian Y; Guappone AC; Baisden JM; Hill MW; Summy JM; Flynn DC
Hybridoma; 1999 Apr; 18(2):167-75. PubMed ID: 10380016
[TBL] [Abstract][Full Text] [Related]
2. Src can regulate carboxy terminal interactions with AFAP-110, which influence self-association, cell localization and actin filament integrity.
Qian Y; Baisden JM; Westin EH; Guappone AC; Koay TC; Flynn DC
Oncogene; 1998 Apr; 16(17):2185-95. PubMed ID: 9619827
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the role of the leucine zipper motif in regulating the ability of AFAP-110 to alter actin filament integrity.
Qian Y; Gatesman AS; Baisden JM; Zot HG; Cherezova L; Qazi I; Mazloum N; Lee MY; Guappone-Koay A; Flynn DC
J Cell Biochem; 2004 Feb; 91(3):602-20. PubMed ID: 14755689
[TBL] [Abstract][Full Text] [Related]
4. The carboxy terminus of AFAP-110 modulates direct interactions with actin filaments and regulates its ability to alter actin filament integrity and induce lamellipodia formation.
Qian Y; Baisden JM; Zot HG; Van Winkle WB; Flynn DC
Exp Cell Res; 2000 Feb; 255(1):102-13. PubMed ID: 10666339
[TBL] [Abstract][Full Text] [Related]
5. The actin filament-associated protein AFAP-110 is an adaptor protein that modulates changes in actin filament integrity.
Baisden JM; Qian Y; Zot HM; Flynn DC
Oncogene; 2001 Oct; 20(44):6435-47. PubMed ID: 11607843
[TBL] [Abstract][Full Text] [Related]
6. Formation of a stable src-AFAP-110 complex through either an amino-terminal or a carboxy-terminal SH2-binding motif.
Guappone AC; Weimer T; Flynn DC
Mol Carcinog; 1998 Jun; 22(2):110-9. PubMed ID: 9655255
[TBL] [Abstract][Full Text] [Related]
7. The intrinsic ability of AFAP-110 to alter actin filament integrity is linked with its ability to also activate cellular tyrosine kinases.
Baisden JM; Gatesman AS; Cherezova L; Jiang BH; Flynn DC
Oncogene; 2001 Oct; 20(45):6607-16. PubMed ID: 11641786
[TBL] [Abstract][Full Text] [Related]
8. The integrity of the SH3 binding motif of AFAP-110 is required to facilitate tyrosine phosphorylation by, and stable complex formation with, Src.
Guappone AC; Flynn DC
Mol Cell Biochem; 1997 Oct; 175(1-2):243-52. PubMed ID: 9350057
[TBL] [Abstract][Full Text] [Related]
9. Identification and sequence analysis of cDNAs encoding a 110-kilodalton actin filament-associated pp60src substrate.
Flynn DC; Leu TH; Reynolds AB; Parsons JT
Mol Cell Biol; 1993 Dec; 13(12):7892-900. PubMed ID: 8247004
[TBL] [Abstract][Full Text] [Related]
10. AFAP-120. A variant form of the Src SH2/SH3-binding partner AFAP-110 is detected in brain and contains a novel internal sequence which binds to a 67-kDa protein.
Flynn DC; Koay TC; Humphries CG; Guappone AC
J Biol Chem; 1995 Feb; 270(8):3894-9. PubMed ID: 7876134
[TBL] [Abstract][Full Text] [Related]
11. Preparation and Characterization of a Polyclonal Antibody against Human Actin Filament-Associated Protein-120 kD.
Chen Y; Liu Y; Guo J; Tang T; Gao J; Huang T; Wang B; Liu S
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322249
[TBL] [Abstract][Full Text] [Related]
12. Protein expression levels of the Src activating protein AFAP are developmentally regulated in brain.
Clump DA; Clem R; Qian Y; Guappone-Koay A; Berrebi AS; Flynn DC
J Neurobiol; 2003 Feb; 54(3):473-85. PubMed ID: 12532398
[TBL] [Abstract][Full Text] [Related]
13. Autoantigenic epitopes of the B and D polypeptides of the U1 snRNP. Analysis of domains recognized by the Y12 monoclonal anti-Sm antibody and by patient sera.
Hirakata M; Craft J; Hardin JA
J Immunol; 1993 Apr; 150(8 Pt 1):3592-601. PubMed ID: 7682245
[TBL] [Abstract][Full Text] [Related]
14. PC phosphorylation increases the ability of AFAP-110 to cross-link actin filaments.
Qian Y; Baisden JM; Cherezova L; Summy JM; Guappone-Koay A; Shi X; Mast T; Pustula J; Zot HG; Mazloum N; Lee MY; Flynn DC
Mol Biol Cell; 2002 Jul; 13(7):2311-22. PubMed ID: 12134071
[TBL] [Abstract][Full Text] [Related]
15. PI3K activation is required for PMA-directed activation of cSrc by AFAP-110.
Walker VG; Ammer A; Cao Z; Clump AC; Jiang BH; Kelley LC; Weed SA; Zot H; Flynn DC
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C119-32. PubMed ID: 17360811
[TBL] [Abstract][Full Text] [Related]
16. Actin filament structure probed with monoclonal antibodies.
Moncman CL; Peng I; Winkelmann DA
Cell Motil Cytoskeleton; 1993; 25(1):73-86. PubMed ID: 7686087
[TBL] [Abstract][Full Text] [Related]
17. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.
Summy JM; Guappone AC; Sudol M; Flynn DC
Oncogene; 2000 Jan; 19(1):155-60. PubMed ID: 10644991
[TBL] [Abstract][Full Text] [Related]
18. Towards the definition of a chimpanzee and human conserved CD6 domain 1 epitope recognized by T1 monoclonal antibody.
Alonso R; Huerta V; de Leon J; Piedra P; Puchades Y; Guirola O; Chinea G; Montero E
Hybridoma (Larchmt); 2008 Aug; 27(4):291-301. PubMed ID: 18707547
[TBL] [Abstract][Full Text] [Related]
19. Anti-hirudin monoclonal antibodies directed toward discontinuous epitopes of the hirudin amino-terminal and epitopes involving the carboxy-terminal hirudin amino acids.
Koch C; Whitechurch O; Cordier P; Roitsch C
Anal Biochem; 1993 Oct; 214(1):301-12. PubMed ID: 7504411
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies directed to human and equine chorionic gonadotropins as probes for the topographic analysis of epitopes on the human alpha-subunit.
Bidart JM; Troalen F; Bousfield GR; Bohuon C; Bellet D
Endocrinology; 1989 Feb; 124(2):923-9. PubMed ID: 2463907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
